Cargando…
When Does the IC(50) Accurately Assess the Blocking Potency of a Drug?
[Image: see text] Preclinical assessment of drug-induced proarrhythmicity is typically evaluated by the potency of the drug to block the potassium human ether-à-go-go-related gene (hERG) channels, which is currently quantified by the IC(50). However, channel block depends on the experimental conditi...
Autores principales: | Gomis-Tena, Julio, Brown, Brandon M., Cano, Jordi, Trenor, Beatriz, Yang, Pei-Chi, Saiz, Javier, Clancy, Colleen E., Romero, Lucia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7357848/ https://www.ncbi.nlm.nih.gov/pubmed/32105478 http://dx.doi.org/10.1021/acs.jcim.9b01085 |
Ejemplares similares
-
Gene-signature-derived IC(50)s/EC(50)s reflect the potency of causative upstream targets and downstream phenotypes
por: Renner, Steffen, et al.
Publicado: (2020) -
Problemas resueltos de electrónica analógica
por: Trénor Gomis, Beatriz
Publicado: (2002) -
Ranolazine as an Alternative Therapy to Flecainide for SCN5A V411M Long QT Syndrome Type 3 Patients
por: Cano, Jordi, et al.
Publicado: (2020) -
An Open-Circuit Indirect Calorimetry Head Hood System for Measuring Methane Emission and Energy Metabolism in Small Ruminants
por: Fernández, Carlos, et al.
Publicado: (2019) -
Variations in IC(50) Values with Purity of Mushroom Tyrosinase
por: Neeley, Elizabeth, et al.
Publicado: (2009)